FUSION trial data published show FFRCT added to CCTA safely cut unnecessary catheterizations. One-year results from the ...
New multi-center registry data confirm MAC as the dominant cause of NTM pulmonary disease, while culture conversion with standard therapy still fails in nearly half of patients. This episode, "New ...
In "Why FACT Accreditation Still Matters for CAR T-Cell Therapy," the discussion turns to why FACT accreditation for CAR T-cell therapy access has held up over 25 years.
Population Health, Equity & Outcomes is a quarterly publication dedicated to providing a platform for the exchange of research, policy analysis, and insights that aim to improve health outcomes and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results